Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Birth weight in relation to morbidity and mortality among newborn infants.N Engl J Med. 1999; 340: 1234-1238
- Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia.Biol Reprod. 2003; 69: 1-7
- Pathogenesis and genetics of pre-eclampsia.Lancet. 2001; 357: 53-56
- Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia.Placenta. 2000; 21: S25-S30
- Intrauterine growth restriction, human placental development and trophoblast cell death.J Physiol. 2009; 587: 3453-3458
- Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy.Placenta. 2009; 30: 473-482
- Preeclampsia: an endothelial cell disorder.Am J Obstet Gynecol. 1989; 161: 1200-1204
- Elevated circulating thrombomodulin in severe preeclampsia.Am J Obstet Gynecol. 1993; 169: 148-149
- Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.JAMA. 1999; 282: 356-362
- High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone.Am J Obstet Gynecol. 1991; 165: 895-901
- Is pre-eclampsia more than one disease?.BJOG. 2004; 111: 298-302
- The frequency and severity of placental findings in women with preeclampsia are gestational age dependent.Am J Obstet Gynecol. 2003; 189: 1173-1177
- Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction.BJOG. 2006; 113: 580-589
- First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia.Ultrasound Obstet Gynecol. 2008; 32: 133-137
- Subclassification of preeclampsia.Hypertens Pregnancy. 2003; 22: 143-148
- Schulz K.F. Grimes D.A. The Lancet handbook of essential concepts in clinical research. Elsevier, Philadelphia (PA)2006: 79
- Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group.JAMA. 1994; 271: 703-707
- Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia.Int J Gynaecol Obstet. 2004; 85: S28-S41
- Lindheimer M.D. Roberts J.M. Cunningham F.G. Chesley's hypertensive disorders in pregnancy. 3rd edition. Elsevier, Oxford (UK)2009
- How to report statistics in medicine.American College of Physicians, Philadelphia1997
- Riegelman R.K. Hirsch R. Studying a study and testing a test. 2nd edition. Little, Brown and Co, Boston1987
- Prediction of preeclampsia: can it be achieved?.Obstet Gynecol Surv. 2004; 59 ([quiz: 485]): 464-482
- World Health Organization systematic review of screening tests for preeclampsia.Obstet Gynecol. 2004; 104: 1367-1391
- Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11–14 weeks' gestation.Ultrasound Obstet Gynecol. 2007; 29: 135-140
- Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images.Am J Obstet Gynecol. 2008; 198 (e1–7): 330
- Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis.CMAJ. 2008; 178: 701-711
- Use of Doppler ultrasonography to predict pre-eclampsia.CMAJ. 2008; 179 ([author reply: 53–4]): 53
- Imaging of placental vasculature using three-dimensional ultrasound and color power Doppler: a preliminary study.Ultrasound Obstet Gynecol. 1998; 12: 45-49
- 3-dimensional colour power angiography for staging human placental development.Lancet. 2003; 362: 1199-1201
- Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population.Ultrasound Obstet Gynecol. 2006; 27: 652-657
- Effects of maternal cigarette smoking on placental volume and vascularization measured by 3-dimensional power Doppler ultrasonography at 11 + 0 to 13 + 6 weeks of gestation.Am J Obstet Gynecol. 2009; 200 (e1–5): 415
- The assessment of placental blood vessels by three-dimensional power Doppler ultrasound.J Perinat Med. 2002; 30: 26-32
- Reproducibility of the study of placental vascularization by three-dimensional power Doppler.J Perinat Med. 2004; 32: 228-233
- Validation of placental vascular sonobiopsy for obtaining representative placental vascular indices by three-dimensionalpower Doppler ultrasonography.Placenta. 2010; 31: 192-196
- Assessment of placental vascularization by three-dimensional power Doppler “vascular biopsy” in normal pregnancies.Croat Med J. 2005; 46: 765-771
- Placental vascular sonobiopsy using three-dimensional power Doppler ultrasound in normal and growth restricted fetuses.Placenta. 2009; 30: 391-397
- Is three-dimensional power Doppler ultrasound useful in the assessment of placental perfusion in normal and growth-restricted pregnancies?.Ultrasound Obstet Gynecol. 2008; 31: 171-176
- Methodological considerations for the correct application of quantitative three-dimensional power Doppler angiography.Ultrasound Obstet Gynecol. 2008; 32 ([author reply: 117–8]): 115-117
- Determining the relationship between three-dimensional power Doppler data and true blood flow characteristics: an in-vitro flow phantom experiment.Ultrasound Obstet Gynecol. 2008; 32: 540-550
- Evaluation of the effect of machine settings on quantitative three-dimensional power Doppler angiography: an in-vitro flow phantom experiment.Ultrasound Obstet Gynecol. 2008; 32: 551-559
- Evaluation of volume vascularization index and flow index: a phantom study.Ultrasound Obstet Gynecol. 2008; 32: 560-564
- Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries.Placenta. 2004; 25: 735-741
- Usefulness of a placental profile in high-risk pregnancies.Am J Obstet Gynecol. 2007; 196 (e1–7): 363
- Current topic: pre-eclampsia and the placenta.Placenta. 1991; 12: 301-308
- Evaluation of elevations in maternal serum alpha-fetoprotein: a review.Obstet Gynecol Surv. 1990; 45: 269-283
- Screening for placental insufficiency in high-risk pregnancies: is earlier better?.Placenta. 2008; 29: 1034-1040
- Nuclear factor-kappa B, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins.Am J Pathol. 2007; 170: 1511-1520
- Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia.Am J Pathol. 2004; 164: 1049-1061
- Trophoblastic oxidative stress and the release of cell-free feto-placental DNA.Am J Pathol. 2006; 169: 400-404
- Platelets and the beginnings of preeclampsia.N Engl J Med. 1990; 323: 478-480
- Plasma P-selectin is elevated in the first trimester in women who subsequently develop pre-eclampsia.BJOG. 2001; 108: 709-715
- Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis.BMC Pregnancy Childbirth. 2008; 8: 33
- ADAMs, a disintegrin and metalloproteinases, mediate shedding of oxytocinase.Biochem Biophys Res Commun. 2004; 314: 1008-1013
- The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading.J Cell Biol. 2000; 149: 1143-1156
- Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia.Obstet Gynecol. 2005; 106: 144-149
- ADAM12s in maternal serum as a potential marker of pre-eclampsia.Prenat Diagn. 2008; 28: 212-216
- First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system.Prenat Diagn. 2007; 27: 264-271
- First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome.Obstet Gynecol. 2008; 112: 1082-1090
- A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound.Ultrasound Obstet Gynecol. 2006; 27: 13-17
- First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.Am J Obstet Gynecol. 2007; 197 (e1–7): 35
- PP13 mRNA expression in trophoblasts from preeclamptic placentas.Reprod Sci. 2009; 16: 408-413
- First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes.Prenat Diagn. 2008; 28: 121-125
- First-trimester maternal serum PP13 in the risk assessment for preeclampsia.Am J Obstet Gynecol. 2008; 199 (e1–11): 122
- Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study.BJOG. 2008; 115: 1465-1472
- Longitudinal determination of serum placental protein 13 during development of preeclampsia.Fetal Diagn Ther. 2008; 24: 230-236
- Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia.Prenat Diagn. 2009; 29: 1103-1108
- Preeclampsia and angiogenic imbalance.Annu Rev Med. 2008; 59: 61-78
- Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia.Am J Obstet Gynecol. 2005; 193: 185-191
- Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.J Clin Invest. 2003; 111: 649-658
- Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria.J Biol Chem. 2003; 278: 12605-12608
- Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies.Am J Obstet Gynecol. 2003; 188: 177-182
- Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.Ultrasound Obstet Gynecol. 2008; 31: 303-309
- First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.J Clin Endocrinol Metab. 2004; 89: 770-775
- Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension.Hypertens Pregnancy. 2008; 27: 65-73
- Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia.Hypertension. 2005; 46: 1077-1085
- Angiogenic factors for the prediction of preeclampsia in high-risk women.Am J Obstet Gynecol. 2007; 197 (e1–8): 244
- Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.Ultrasound Obstet Gynecol. 2008; 32: 732-739
- A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.J Matern Fetal Neonatal Med. 2009; 22: 1021-1038
- First trimester urinary placental growth factor and development of pre-eclampsia.BJOG. 2009; 116: 643-647
- Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.Hypertension. 2007; 50: 137-142
- Circulating soluble endoglin and placental abruption.Prenat Diagn. 2008; 28: 852-858
- First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.Am J Obstet Gynecol. 2008; 199 (e1–6): 266
- A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets.J Biol Chem. 1984; 259: 9121-9126
- PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes.Cell. 1989; 59: 305-312
- Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: their significances.Am J Obstet Gynecol. 1996; 174: 272-277
- Performance of a panel of maternal serum markers in predicting preeclampsia at 11–15 weeks' gestation.Prenat Diagn. 2007; 27: 1005-1010
- First trimester sex hormone-binding globulin and subsequent development of preeclampsia or other adverse pregnancy outcomes.Hypertens Pregnancy. 2005; 24: 303-311
- Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia.Am J Epidemiol. 1999; 149: 323-329
- Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia.Eur J Obstet Gynecol Reprod Biol. 2002; 100: 143-145
- TNF-receptor levels in preeclampsia–results of a longitudinal study in high-risk women.J Matern Fetal Neonatal Med. 2005; 18: 283-287
- First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia.Ultrasound Obstet Gynecol. 2009; 33: 135-141
- First trimester insulin resistance and subsequent preeclampsia: a prospective study.J Clin Endocrinol Metab. 2002; 87: 1563-1568
- Adiponectin and insulin resistance in early- and late-onset pre-eclampsia.BJOG. 2006; 113: 1264-1269
- A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2.Am J Hum Genet. 2000; 67: 1581-1585
- A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q.Am J Hum Genet. 1997; 60: 1158-1167
- Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia.Prenat Diagn. 2008; 28: 956-961
- Altered global gene expression in first trimester placentas of women destined to develop preeclampsia.Placenta. 2009; 30: 15-24
- Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction.Am J Obstet Gynecol. 2009; 200 (e1–6): 98
- Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction–a pilot study.Prenat Diagn. 2003; 23: 367-371
- Disturbed feto-maternal cell traffic in preeclampsia.Obstet Gynecol. 1998; 91: 669-672
- Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia.Clin Chem. 1999; 45: 184-188
- Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall.Am J Pathol. 1999; 155: 293-301
- Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia.Am J Obstet Gynecol. 2004; 191: 515-520
- Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia.Prenat Diagn. 2007; 27: 174-179
- Replicating genotype-phenotype associations.Nature. 2007; 447: 655-660
- First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia.Ultrasound Obstet Gynecol. 2009; 33: 23-33
- Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia.Ultrasound Obstet Gynecol. 2008; 32: 138-146
- Pre-eclampsia.Lancet. 2005; 365: 785-799
- Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor.Am J Obstet Gynecol. 2007; 196 (e1–13): 326
- First-trimester prediction of hypertensive disorders in pregnancy.Hypertension. 2009; 53: 812-818
- Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11–13 weeks.Ultrasound Obstet Gynecol. 2009; 34: 497-502
Article info
Footnotes
Funding support: none.
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
